CRNX
Crinetics Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$84.95
+0.00%Next report
Analyst consensus
- Next report date
- Nov 5, 2026
- EPS estimate
- -$1.20
- Revenue estimate
- $21.0M
Latest reported
- Last report date
- Aug 4, 2026
- EPS actual
- -$1.14
- EPS estimate
- -$1.18
- Revenue actual
- $25.1M
- Revenue estimate
- $14.8M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 2
- EPS misses (12Q)
- 8
- EPS in line (12Q)
- 2
- Avg surprise (4Q)
- -3.7%
- Revenue beats (12Q)
- 8
Analyst ratings
Sell-side consensus
- Consensus
- Hold
- Price target
- $85
- PT range
- $85 – $85
- Analysts
- 9
1 Buy8 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 4, 2026 | -$1.18 | -$1.14 | Beat 3.39% | $25.1M |
| May 7, 2026 | -$1.22 | -$1.23 | Miss -0.82% | $10.7M |
| Nov 6, 2025 | -$1.27 | -$1.38 | Miss -8.66% | $143.0K |
| Aug 7, 2025 | -$1.13 | -$1.23 | Miss -8.85% | $1.0M |
| May 8, 2025 | -$0.99 | -$1.04 | Miss -5.05% | $361.0K |
| Feb 27, 2025 | -$0.92 | -$0.88 | Beat 4.35% | — |
| Aug 8, 2024 | -$0.86 | -$0.94 | Miss -9.30% | $399.0K |
| May 9, 2024 | -$0.84 | -$0.93 | Miss -10.71% | $640.0K |
| Feb 28, 2024 | -$0.89 | -$0.90 | Miss -1.12% | — |
| May 4, 2023 | -$0.82 | -$0.85 | Miss -3.66% | $2.7M |
| Feb 28, 2023 | -$0.82 | -$0.84 | Miss -2.44% | $709.0K |
| Nov 14, 2022 | -$0.78 | -$0.78 | In line | $458.0K |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 5, 2026